Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04537832 · ClinicalTrials.gov registry record
Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies
A clinical trial, sponsored by Encoded Therapeutics.
- Terminated
- Registry status
- 58
- Enrollment target
NCT04537832 is a clinical trial that was terminated before completion, run by Encoded Therapeutics. The registered enrollment target is 58 participants.
The verdict
NCT04537832 was terminated before completion, sponsored by Encoded Therapeutics.
- TERMINATED
- Registry status
- 58 participants
- Enrollment target
Study Summary
This is a multicenter, prospective, 2-year observational study in infants and children with developmental and epileptic encephalopathies (DEEs). The DEE currently being investigated is SCN1A-positive Dravet Syndrome.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2021-01-18 |
| Est. Completion | 2023-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04537832
The ClinicalTrials.gov registry entry for NCT04537832 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Encoded Therapeutics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT04537832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04537832 about?
NCT04537832 is a clinical study titled "Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies". This is a multicenter, prospective, 2-year observational study in infants and children with developmental and epileptic encephalopathies (DEEs). The DEE currently being investigated is SCN1A-positive Dravet Syndrome.
What is the current status of trial NCT04537832?
This trial is currently terminated. The enrollment target is 58 participants. The study started on 2021-01-18. Estimated completion is 2023-03-31.
What interventions are being tested in trial NCT04537832?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT04537832?
This trial is sponsored by Encoded Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.